Neue Suche | Kongressdetail
mail
Druckansicht
 
 

2nd CRISPR-Based Therapy Analytical Development Summit

Evvnt Promotion / evvnt
-
17.09.2024 - 19.09.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Kongressthemen
As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2433843-3?pid=4832

Speakers: Andrew Kernytsky, Principal Consultant, Next Gen Editing, Bryant Chia, Scientist, Analytical Chemistry and Structural Biology, Editas Medicine, and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2433843-2?pid=4832
Frau Jasmine Fletcher
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 5796.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Alumni Club Medizinische Universität WienAMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarionewTreeÄrztekammer für WienCenter of ExcellenceÖsterreichische Gesellschaft für Public Health